Chronic wound infection: Facts and controversies

Clinics in Dermatology

Volumn 28, Issue 5, 2010, Pages 519-526

  Siddiqui, Abdul R ^a,b   Bernstein, Jack M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ALCOHOL; AMIKACIN; ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; CETRIMIDE; CHLORHEXIDINE; CIPROFLOXACIN; COTRIMOXAZOLE; EUSOL; GENTAMICIN; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; NEOMYCIN; PLACEBO; POVIDONE IODINE; SILVER NITRATE; SULFADIAZINE SILVER; TRICLOCARBAN; TRICLOSAN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTISEPSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOFILM; CHRONIC WOUND; CLINICAL FEATURE; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTACT ALLERGY; DEBRIDEMENT; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; HUMAN; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN ULCER; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; ULCER HEALING; WOUND INFECTION;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BIOFILMS; CHRONIC DISEASE; HUMANS; WOUND INFECTION;

EID: 77955942916     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.03.009     Document Type: Article

References (81)

1. Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg 2004, 187:38S-43S.
2. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004, 187(5 Suppl 1):S65-S70.
3. Kruse I., Edelman S. Evaluation and treatment of diabetic foot ulcers. Clin Diabet 2006, 24:91-93.
4. Barone E.J., Yager D.R., Pozez A.L., et al. Interleukin-1 alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 1998, 102:1023-1027.
5. Walmsley S. Advances in wound management: executive summary 2002, Clinica Reports, PJB Publications, Ltd., London.
6. Fowler E. Chronic wounds: an overview. Chronic wound care: a clinical source book for healthcare professionals 1990, 12-18. Health Management Publications Inc, King of Prussia, PA. D. Krasner (Ed.).
7. Singh A., Halder S., Menon G.R., et al. Meta-analysis of randomized controlled trials on hydrocolloid occlusive dressing versus conventional gauze dressing in the healing of chronic wounds. Asian J Surg 2004, 27:326-332.
8. Brunicardi F. Charles Schwartz's principles of surgery 2004, McGraw-Hill, New York. 8th ed.
9. Frank C, Bayoumi I, Westendorp C Approach to infected skin ulcers. Can Fam Physician 2005, 51:1352-1359.
10. Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage 2003, 49:S1-S7.
11. Laato M., Niinikoski J., Lundberg C., et al. Inflammatory reaction and blood flow in experimental wounds inoculated with Staphylococcus aureus. Eur Surg Res 1988, 20:33-38.
12. Ovington L. Bacterial toxins and wound healing. Ostomy Wound Manage 2003, 49(7 Suppl A):8-12.
13. Cutting K.F., White R.J. Criteria for identifying wound infection-revisited. Ostomy Wound Manage 2005, 51:28-34.
14. Salcido R. What is bioburden? The link to chronic wounds. Adv Skin Wound Care 2007, 20:368.
15. Wysocki A.B. Evaluating and managing open skin wounds: colonization versus infection. AACN Clin Issues 2002, 13:382-397.
16. Bowler P.G., Duerden B.I., Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001, 14:244-269.
17. Hansson C., Hoborn J., Moller A., et al. The microbial flora in venous leg ulcers without clinical signs of infection. Acta Dermato Venereol 1995, 75:24-30.
18. Gjodsbol K., Christensen J., Karlsmark T., et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006, 3:225-231.
19. Bowler P.G., Davies B.J. The microbiology of acute and chronic wounds. Wounds 1999, 11:72-78.
20. Sheffield PJ. Tissue Oxygen Measurements. Problem Wounds: The Role of Oxygen 1988, 17-51. Elsevier, Amsterdam. C.D. Jefferson, T.K. Hunt (Eds.).
21. Landis S.J. Chronic wound infection and antimicrobial use. Adv Skin Wound Care 2008, 21:531-540.
22. Howell-Jones R.S., Wilson M.J., Hill K.E., et al. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005, 55:143-149.
23. Gerding D.N. Foot infections in diabetic patients: the role of anaerobes. Clin Infect Dis 1995, 20(Suppl 2):S283-S288.
24. Hartemann-Heurtier A., Robert J., Jacqueminent S., et al. Diabetic foot ulcer and multidrug resistant organisms: risk factors and impact. Diabet Med 2004, 21:710-715.
25. Trengove N., Stacey M., McGechie D., et al. Qualitative bacteriology and leg ulcer healing. J Wound Care 1996, 5:277-280.
26. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003, 2:114-122.
27. Kievit T.R., Iglewski B.H. Bacterial quorum sensing in pathogenic relationships. Infect Immun 2000, 68:4839-4849.
28. Wolcott R.D., Rhoads D.D. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 1996;17:145-142, 154.
29. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
30. Donlan R.M. Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis 2001, 33:1387-1392.
31. Principles and Practice of Infectious Diseases 2005, 21-22. Elsevier, Philadelphia. 6th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
32. Davis S.C., Martinez L., Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diabet Rep 2006, 6:439-445.
33. Hurlow J., Bowler P.G. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage 2009, 55:38-49.
34. Bamberg R., Sullivan P.K., Conner-Kerr T.A. Diagnosis of wound infections: current culturing practices of US wound care professionals. Wounds 2002, 14:314-327.
35. Cutting K.F., Harding K.G. Criteria for identifying wound infection. J Wound Care 1994, 3:198-201.
36. Serena T.E., Robson M.C., Cooper D.M., et al. Lack of reliability of clinical/visual assessment of chronic wound infection: the incidence of biopsy-proven infection in venous leg ulcers. Wounds 2006, 18:197-202.
37. American Diabetes Association Consensus development conference on diabetic foot wound care. Diabet Care 1999, 22:1354-1360.
38. Douglas W.S., Simpson N.B. Guidelines for the management of chronic venous leg ulceration. Report of a multidisciplinary workshop. Br J Dermatol 1995, 132:446-452.
39. Sibbald R.G., Woo K., Ayello E.A. Increased bacterial burden and infection: the story of NERDS and STONEES. Adv Skin Wound Care 2006, 19:447-463.
40. Woo K.Y., Sibbald R.G. A cross-sectional validation study of using NERDS and STONEES to assess bacterial burden. Ostomy Wound Manage 2009, 55:40-48.
41. Robson M., Heggers J. Bacterial quantification of open wounds. Mil Med 1969, 134:19-24.
42. Robson M. Wound infection: a failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997, 77:637-650.
43. Bergstrom N., Allman R., Alvarez O., et al. Clinical practice guideline number 15: treatment of pressure ulcers. AHCPR Publication 95-0652. Public Health Service. Agency for Health Care Policy and Research 1994, US Department of Health Human Services, Rockville, MD.
44. Gardner S.E., Frantz R.A. Wound bioburden. Wound care essentials practice principles 2004, 91-116. Lippincott, Williams & Wilkins, New York, NY. S. Baranoski, E.A. Ayello (Eds.).
45. Ratliff C.R., Rodeheaver G.T. Correlation of semi-quantitative swab cultures to quantitative swab cultures from chronic wounds. Wounds 2002, 14:329-333.
46. Gardner S.E., Frantz R.A., Hillis S.L., Park H., Scherubel M. Diagnostic validity of semiquantitative swab cultures. Wounds 2007, 19:31-38.
47. Sapico F., Ginunas V., Thornhill-Joynes M., et al. Quantitative microbiology of pressure sores in different stages of healing. Diagn Microbiol Infect Dis 1986, 5:31-38.
48. Fleck C. Identifying infection in chronic wounds. Adv Skin Wound Care 2006, 19:20-21.
49. Healy B., Freedman A. ABC of wound healing: infections. BMJ 2006, 332:838-841.
50. Perry C., Pearson R., Miller G. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg Am 1991, 73:745-749.
51. Dow G. Bacterial swabs and the chronic wound: when, how, and what do they mean?. Ostomy Wound Manage 2003, 49(5A Suppl):8-13.
52. Gilchrist B. Taking a wound swab. Nurs Times 2000, 96(Suppl 4):2.
53. Cooper R., Lawrence J. The isolation and identification of bacteria from wounds. J Wound Care 1996, 5:335-340.
54. Sapico F., Witte J., Canawati H., et al. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984, 6(Supp 1):S171-S176.
55. Bonham P.A. Swab cultures for diagnosing wound infections. a literature review and clinical guideline. J Wound Ostomy Continence Nurs 2009, 36:389-395.
56. McDonnell G., Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999, 12:147-179.
57. Wilson J.R., Mills J.G., Prather I.D., et al. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 2005, 18:373-378.
58. Cooper R. A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds http://www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobia.
59. Ebright J.R. Microbiology of chronic leg and pressure ulcers: clinical significance and implications for treatment. Nurs Clin North Am 2005, 40:207-216.
60. Eron L.J., Lipsky B.A., Low D.E., et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003, 52(Suppl 1):i3-i17.
61. Local applications to wounds: 1. Cleansers, antibacterials, debriders. Drug Therapeut Bull 1991, 29:93-95.
62. Zaki I., Shall L., Dalziel K.L. Bacitracin: a significant sensitizer in leg ulcer patients?. Contact Dermatitis 1994, 31:92-94.
63. Darsow U. The European Task Force on Atopic Dermatitis. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol 2005, 19:286-295.
64. Editorial. BMJ 1977, 1:494.
65. Alinovi A., Bassissi P., Pini M. Systemic administration of antibiotics in the management of venous ulcers. J Am Acad Dermatol 1986, 15:186-191.
66. Huovinen S., Kotilainen P., Jarvinen H., et al. Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study. J Am Acad Dermatol 1994, 31:279-281.
67. Fraki J.E., Peltonen L., Hopsu-Havu V.K. Allergy to various components of topical preparations in stasis dermatitis and leg ulcer. Contact Dermatitis 1979, 5:97-100.
68. The International Consensus on the Diabetic Foot 1999, The International Working Group on the Diabetic Foot, The International Working Group on the Diabetic Foot, Amsterdam, Netherlands.
69. National Institute for Clinical Excellence Type 2 diabetes. Prevention and management of foot problems. Clinical Guideline 10 2004, National Institute for Clinical Excellence, London, UK.
70. Scottish Intercollegiate Guidelines Network (SIGN) The care of patients with chronic leg ulcer. A national clinical guideline. No. 26 1998, SIGN Publication, Edinburgh, UK.
71. Tammelin A., Lindholm C., Hambraeus A. Chronic ulcers and antibiotic treatment. J Wound Care 1998, 7:435-437.
72. Centers for Disease Control and Prevention Staphylococcus aureus resistant to vancomycin-United States. Morbid Mortal Wkly Rep 2002, 51:565-567.
73. Centers for Disease Control and Prevention Public health dispatch: vancomycin-resistant Staphylococcus aureus-Pennsylvania. Morbid Mortal Wkly Rep 2002, 51:902.
74. Colsky A.S., Kirsner R.S., Kerdel F.A. Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol 1998, 134:L1006-1009.
75. Valtonen V., Karppinen L., Kariniemi A.L. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods. Scand J Infect Dis Suppl 1989, 60:79-83.
76. O'Meara S., Al-Kurdi D., Ovington L.G. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008, CD003557.
77. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004, 39:885-910.
78. Schultz G.S., Sibbald R.G., Falanga V., et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Reg 2003, 11:S1-S28.
79. Grayson M.L., Gibbons G.W., Balogh K., et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995, 273:721-723.
80. Lipsky B.A., Pecoraro R.E., Larson S.A. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990, 150:790-797.
81. Romanelli M., Magliaro A., Mastronicola D., et al. Systemic antimicrobial therapies for pressure ulcers. Ostomy Wound Manage 2003, 49(5A Suppl):25-29.